Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Clinical Pharmacology

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

JAMA | May 17, 2021 Clinical Pharmacology

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

JAMA Dermatology | May 15, 2021 Clinical Pharmacology

Efficacy and safety of voclosporin vs placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

The Lancet | May 12, 2021 Clinical Pharmacology

Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: A randomized clinical trial

JAMA | May 12, 2021 Clinical Pharmacology

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

British Journal of Dermatology | May 09, 2021 Clinical Pharmacology

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: An open‐label study

Clinical and Experimental Dermatology | May 06, 2021 Clinical Pharmacology

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

The Journal of Rheumatology | May 05, 2021 Clinical Pharmacology

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Rheumatology | May 01, 2021 Clinical Pharmacology

Thyroid immune-related adverse events following immune checkpoint inhibitor treatment

Journal of Clinical Endocrinology and Metabolism | Apr 28, 2021 Clinical Pharmacology

Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis

Journal of Asthma and Allergy | Apr 28, 2021 Clinical Pharmacology

« Prev 1 … 9 10 11 12 13 … 61 Next »

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Efficacy and safety of voclosporin vs placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: A randomized clinical trial

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: An open‐label study

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Thyroid immune-related adverse events following immune checkpoint inhibitor treatment

Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

The Impact of Hormonal Imbalances on Women's Health

Anaesthetic Management in Obese Patients

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Gut Health Disorders and its Management

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Efficacy and safety of voclosporin vs placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: A randomized clinical trial

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: An open‐label study

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Thyroid immune-related adverse events following immune checkpoint inhibitor treatment

Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

The Impact of Hormonal Imbalances on Women's Health

Anaesthetic Management in Obese Patients

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Gut Health Disorders and its Management

Select Specialty

Select Topic